These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25007179)

  • 21. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer.
    Tiainen S; Tumelius R; Rilla K; Hämäläinen K; Tammi M; Tammi R; Kosma VM; Oikari S; Auvinen P
    Histopathology; 2015 May; 66(6):873-83. PubMed ID: 25387851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
    Ding W; Tan Y; Qian Y; Xue W; Wang Y; Jiang P; Xu X
    PLoS One; 2019; 14(10):e0223971. PubMed ID: 31618252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
    Maki A; Kono H; Gupta M; Asakawa M; Suzuki T; Matsuda M; Fujii H; Rusyn I
    Ann Surg Oncol; 2007 Mar; 14(3):1182-90. PubMed ID: 17195915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer.
    Boström MM; Irjala H; Mirtti T; Taimen P; Kauko T; Ålgars A; Jalkanen S; Boström PJ
    PLoS One; 2015; 10(7):e0133552. PubMed ID: 26197470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
    Ajili F; Kourda N; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Feb; 37(1):56-61. PubMed ID: 23383616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
    Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer.
    Li JQ; Yu XJ; Wang YC; Huang LY; Liu CQ; Zheng L; Fang YJ; Xu J
    J Transl Med; 2017 Feb; 15(1):37. PubMed ID: 28202073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer.
    Schmid S; Csanadi A; Kozhuharov N; Tchudjin M; Kayser C; Rawluk J; Passlick B; Werner M; Prasse A; Kayser G
    Anticancer Res; 2018 Jul; 38(7):3913-3918. PubMed ID: 29970512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients.
    Ni YH; Ding L; Huang XF; Dong YC; Hu QG; Hou YY
    Tumour Biol; 2015 Jul; 36(7):5291-8. PubMed ID: 25666753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
    Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
    Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer.
    Cui YL; Li HK; Zhou HY; Zhang T; Li Q
    Asian Pac J Cancer Prev; 2013; 14(2):1003-7. PubMed ID: 23621176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma.
    Yeung OW; Lo CM; Ling CC; Qi X; Geng W; Li CX; Ng KT; Forbes SJ; Guan XY; Poon RT; Fan ST; Man K
    J Hepatol; 2015 Mar; 62(3):607-16. PubMed ID: 25450711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the immunoescape in colorectal cancer liver metastasis.
    Takasu C; Yamashita S; Morine Y; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Yoshimoto T; Shimada M
    PLoS One; 2021; 16(11):e0259940. PubMed ID: 34797860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
    Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
    Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
    Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
    PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
    Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
    Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry.
    Huang YK; Wang M; Sun Y; Di Costanzo N; Mitchell C; Achuthan A; Hamilton JA; Busuttil RA; Boussioutas A
    Nat Commun; 2019 Sep; 10(1):3928. PubMed ID: 31477692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
    Kong LQ; Zhu XD; Xu HX; Zhang JB; Lu L; Wang WQ; Zhang QB; Wu WZ; Wang L; Fan J; Tang ZY; Sun HC
    PLoS One; 2013; 8(3):e59771. PubMed ID: 23555776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.